Evidence map›Paper›PMID 31256719›Full record

ReviewHypertension (Dallas, Tex. : 1979)2019

Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence.

Kazuomi Kario, Daichi Shimbo, Satoshi Hoshide, Ji-Guang Wang, Kei Asayama, Takayoshi Ohkubo, Yutaka Imai, Richard J McManus, Anastasios Kollias, Teemu J Niiranen and 6 more

Abstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. What impacts do the new ESH 2023 guidelines have on the management of hypertension in Japan?Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
  9. Evidence for the surge blood pressure resonance hypothesis as a trigger for cardiovascular disease events.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
  10. Article
  11. Topics 2023 in Hypertension Research leading to guidelines in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Cost-effectiveness of digital therapeutics for essential hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  16. Article
  17. Latest hypertension research to inform clinical practice in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  18. Article
  19. Review
  20. Perspectives of renal denervation from hypertension to heart failure in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kazuomi KarioFrom the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K., S.H.).
Daichi ShimboThe Hypertension Center, Columbia University Medical Center, New York, NY (D.S.).
Satoshi HoshideFrom the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K., S.H.).
Ji-Guang WangHypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network Tokyo, Japan (K.K., S.H., J.-G.W.).
Kei AsayamaDepartment of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.).
Takayoshi OhkuboDepartment of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., T.O.).
Yutaka ImaiTohoku Institute for Management of Blood Pressure, Sendai, Japan (Y.I.).
Richard J McManusNuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom (R.J.M.).
Anastasios KolliasHypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Greece (A.K., G.S.S.).
Teemu J NiiranenNational Institute for Health and Welfare, and Department of Medicine, University of Turku and Turku University Hospital, Finland (T.J.N.).
Gianfranco ParatiDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.).
Bryan WilliamsUCL Institute of Cardiovascular Sciences, University College London, United Kingdom (B.W.).
Michael A WeberDivision of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, Brooklyn (M.A.W.).
Wanpen VongpatanasinHypertension Section, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (W.V.).
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham (P.M.).
George S StergiouHypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Greece (A.K., G.S.S.).

Funding

Department of Health NIHR-RP-02-12-015Department of Health RP-PG-1209-10051Medical Research Council MC_PC_13090
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31256719
PMCPMC6635060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.